New Delhi: India has finally got its vaccine against coronavirus. Two vaccines — Pune-based Serum Institute’s Covishield and Bharat Biotech’s Covaxin — received emergency use approval from the Drugs Controller General of India (DCGI) on Sunday.
Announcing the formal approval for the two vaccines, DCGI Dr VG Somani said they will be administered in two dosages each, India Today reported.
The DCGI approval was given on the basis of recommendations submitted by a coronavirus subject expert committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO).
On Covishield, Somani said the vaccine trial was conducted on 23,745 participants and the overall efficacy was found to be more than 70 per cent. “The Indian data was also found to be comparable with overseas clinical studies,” he said.
“Bharat Biotech’s coronavirus vaccine Covaxin is safe and gives a robust immune response,” the DCGI added.
Asserting that any vaccine with even the slightest safety concern would not be approved, the DCGI said the vaccines that have been approved for emergency use are 110 per cent safe.
Phulbani: Two tribal men were sentenced to life imprisonment by a special court in Odisha's…
New Delhi: It’s been just over two months since Atishi took oath as Delhi’s chief…
Bhubaneswar: In a moment of pride for AIIMS Bhubaneswar, Dr Manita Tamang, a final-year Senior…
Imphal: In view of the surge in violence in troubled Manipur, the Central government will send…
New Delhi/Bhubaneswar: The 7th edition of Odisha Parba got off to a colourful start in…
Mumbai: Celebrity couple Naga Chaitanya and Sobhita Dhulipala are set to walk down the aisle…
Mumbai: Ticket sales for the highly-anticipated Coldplay Infinity concerts across Indian cities kickstarted at 12…
New Delhi: As part of preparations for a trip to Nainital, a man ordered a pack…